28 news items
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
ABBV
AZN
BMY
19 Jun 24
. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
ABBV
AZN
BMY
19 Jun 24
should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because
U.S. Food and Drug Administration Approves Augtyroâ„¢ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors
BMY
13 Jun 24
tumor cohorts has a primary endpoint of objective response rate (ORR) as assessed by Blinded Independent Central Review (BICR
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
BMY
GERN
7 Jun 24
secondary endpoints, with Rytelo demonstrating significantly higher rates of red blood cell transfusion independence (RBC-TI) versus placebo
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
BMY
1 Jun 24
, as assessed by Blinded Independent Central Review (BICR) compared to docetaxel (HR: 0.58; [95% CI, 0.45-0.76]; P <0.0001). Median PFS was 5.5 months
jadn6ocz57r4v4k75p94ar4buls cu66
BMY
CCCC
ONCY
28 May 24
is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected
mrdshsbfymnm4bslc8g1u2m190pow38ogswf7tet9hysyc3
BMY
CCCC
ONCY
28 May 24
is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely
yryahz5wbht6hher9gl4cb2tz3tsezceyqwgrz55zh8 nhit
BMY
23 May 24
transfusion independence and overall survival in lower-risk myelodysplastic syndromes
ywi ex4dci9qxoa3ewp48xo4f7
BMY
21 May 24
independently, enjoys yoga and dance, and is doing really well. We want to get rid of the negative images many of us have of schizophrenia and raise
278l4poxnx6orsx1t6575bpenw 7111dt3
BMY
15 May 24
or complete response per Lugano criteria as assessed by an Independent Review Committee (IRC). The complete response (CR) rate was 73.4% (95% CI: 63.3
tenc0t55ebgb 5hvu8ryfilnnw2gwo4ixiojsiu3b2fn7prnd
BMY
10 May 24
of the trial is progression-free survival (PFS) by RECIST 1.1 per blinded independent central review (BICR) for Arm A vs. Arm C. Secondary endpoints include
zqc5 csfmio
BMY
26 Apr 24
of overall survival (OS) and progression-free survival (PFS) as assessed by Blinded Independent Central Review (BICR). With a median follow up
3lfst fkc088fvnb632icl789wtfpikfqisq6kdc0mkves1
BMY
25 Apr 24
Independent
vz6fo9eds92cou37160qowcj7c4tpos6noyc5w
ABBV
ATNM
AZN
19 Apr 24
is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com
bmszyqor7tst5siykbrgyie0mxdnkzbdy4knky2yq15zu48hzi4y9tzl1
ATNM
AZN
BMY
18 Apr 24
. No current owner, employee, or independent contractor of InvestorBrandMedia.com is registered as a securities broker-dealer, broker, investment advisor
o4nx7m6xsl8izrt4h1uf52xq cae
ATNM
AZN
BMY
17 Apr 24
broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com is registered as a securities broker-dealer, broker, investment
r94b5tr3qma1hoh 4649ccsz
BMY
6 Apr 24
, people living with schizophrenia often struggle to maintain employment, live independently, and manage relationships. While current treatments can